Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
about
Rapid generation of drug-resistance alleles at endogenous loci using CRISPR-Cas9 indel mutagenesis.Biological function and histone recognition of family IV bromodomain-containing proteins.Bromodomain inhibitors and cancer therapy: From structures to applications.Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities.BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors.Chemical probes and inhibitors of bromodomains outside the BET family.Target validation: Switching domains.Palladium-catalysed stereoselective synthesis of 4-(diarylmethylidene)-3,4-dihydroisoquinolin-1(2H)-ones: expedient access to 4-substituted isoquinolin-1(2H)-ones and isoquinolines.Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands.A TFIID-SAGA Perturbation that Targets MYB and Suppresses Acute Myeloid Leukemia.Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.Regulation of embryonic haematopoietic multipotency by EZH1.Vitamin D Switches BAF Complexes to Protect β Cells.Genetics and epigenetics of pediatric leukemia in the era of precision medicine
P2860
Q36288331-1353A306-FA7A-4336-9EF2-4C9779A01DCCQ38788315-4369CE0C-64F9-485A-99C8-3D369A84E0CEQ39027056-4D7C39E8-EEBB-4F61-88AB-D725119D55A1Q39229171-76BA40EE-9BF0-44AE-9E95-6FC25A8D6D60Q41183040-F3445CC0-C232-410F-9E87-30A379AC76EEQ47128083-21AFCFB5-EC35-4445-B240-5F49324CF55FQ48105865-FC947040-C0E5-4D74-86E5-29ADDAA192C8Q48230914-3C1D1ED9-A36E-42D4-AFE4-C3C84C943F37Q48265414-E91C23CF-8BE9-4D2A-9D9D-0280B69AFA00Q48544889-788CC194-F8E2-4BA5-864B-4A8517729CD2Q49647261-0AAADF4B-DD1A-4D28-94F2-AEE4AA9B855CQ50001698-13DF3D80-BBED-4503-95E9-D0FC55451315Q53672883-E6E3EF39-6CBD-4C5F-BB8E-C8BF7EBAF091Q57175475-F0934CD9-18A6-45D1-8BD6-2EAD3EE50C3C
P2860
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
@ast
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
@en
type
label
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
@ast
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
@en
prefLabel
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
@ast
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
@en
P2093
P2860
P3181
P356
P1476
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
@en
P2093
Anja F Hohmann
Christopher R Vakoc
Darryl McConnell
Diane Thompson
Gerd Bader
Jae-Seok Roe
Jessica L Minder
Junwei Shi
Laetitia J Martin
Manfred Koegl
P2860
P2888
P3181
P356
10.1038/NCHEMBIO.2115
P407
P577
2016-09-01T00:00:00Z
P6179
1035343311